Silihan lan utang jangka dawa perusahaan: Organovo Holdings Inc (ONVO)

The market trend for Organovo Holdings, Inc. (ONVO) shares on GURU.Markets is recorded at 0.00. Organovo Holdings, Inc. (ONVO) creates a 3D bioprinting environment, helping drug developers minimize errors before trials begin. The production cycle relies on California centers with duplicated precision equipment. The biotech's current success is tied to the effectiveness of combating liver fibrosis and the influx of investment into scientific research.

For Organovo Holdings, Inc. (ONVO), long-term liabilities serve as a survival tool amid the costly development of 3D bioprinting. This metric aggregates all loans and borrowings with maturities exceeding one year, determining the overall debt load. By analyzing the business's long-term borrowed capital, an investor assesses the stability of the balance sheet structure. The upward trend reflects a search for external financing to cover operational deficits, signaling the company's high dependence on borrowed funds.